Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018. by Rodríguez-Sánchez, B. et al.
1www.eurosurveillance.org
Review
Review of the impact of MALDI-TOF MS in public 
health and hospital hygiene, 2018
Belén Rodríguez-Sánchez1,2,3, Emilia Cercenado1,2,4, Alix T. Coste5, Gilbert Greub3,5,6
1. Department of Clinical Microbiology and Infectious Diseases, Hospital General Universitario Gregorio Marañón, Madrid, Spain
2. Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
3. These authors contributed equally to this work
4. Department of Medicine, Faculty of Medicine, Universidad Complutense de Madrid, Madrid, Spain
5. Institute of Microbiology, University Hospital of Lausanne, Lausanne, Switzerland
6. Infectious Diseases Service, University Hospital of Lausanne, Lausanne, Switzerland
Correspondence: Belén Rodriguez-Sanchez (mbelen.rodriguez@iisgm.com)
Citation style for this article: 
Rodríguez-Sánchez Belén, Cercenado Emilia, Coste Alix T., Greub Gilbert. Review of the impact of MALDI-TOF MS in public health and hospital hygiene, 2018. Euro 
Surveill. 2019;24(4):pii=1800193. https://doi.org/10.2807/1560-7917.ES.2019.24.4.1800193
Article submitted on 15 Apr 2018 / accepted on 04 Jan 2019 / published on 24 Jan 2019
Introduction: MALDI-TOF MS represents a new tech-
nological era for microbiology laboratories. Improved 
sample processing and expanded databases have 
facilitated rapid and direct identification of micro-
organisms from some clinical samples. Automated 
analysis of protein spectra from different microbial 
populations is emerging as a potential tool for epide-
miological studies and is expected to impact public 
health. Aim: To demonstrate how implementation of 
MALDI-TOF MS has changed the way microorganisms 
are identified, how its applications keep increasing 
and its impact on public health and hospital hygiene.
Methods: A review of the available literature in 
PubMED, published between 2009 and 2018, was 
carried out. Results: Of 9,709 articles retrieved, 108 
were included in the review. They show that rapid 
identification of a growing number of microorgan-
isms using MALDI-TOF MS has allowed for optimisa-
tion of patient management through prompt initiation 
of directed antimicrobial treatment. The diagnosis of 
Gram-negative bacteraemia directly from blood cul-
ture pellets has positively impacted antibiotic stream-
lining, length of hospital stay and costs per patient. 
The flexibility of MALDI-TOF MS has encouraged new 
forms of use, such as detecting antibiotic resistance 
mechanisms (e.g. carbapenemases), which provides 
valuable information in a reduced turnaround time. 
MALDI-TOF MS has also been successfully applied 
to bacterial typing. Conclusions: MALDI-TOF MS is a 
powerful method for protein analysis. The increase in 
speed of pathogen detection enables improvement of 
antimicrobial therapy, infection prevention and control 
measures leading to positive impact on public health. 
For antibiotic susceptibility testing and bacterial typ-
ing, it represents a rapid alternative to time-consum-
ing conventional techniques.
Introduction
During the past 10 years, Matrix Assisted Laser 
Desorption Ionization-Time of Flight Mass Spectrometry 
(MALDI-TOF MS) has changed microbiology routine 
practice by allowing timely and cost-effective identifi-
cation of different microorganisms, not only from pure 
culture but also directly from clinical samples [1-3]. 
Indeed, faster microbial identification allows for earlier 
antibiotic streamlining, due to the accurate identifica-
tion provided for important groups of microorganisms 
that can be managed with directed antibiotic treat-
ment, as demonstrated when MALDI-TOF MS was 
applied to bacterial identification directly from blood 
culture pellets [4,5]. MALDI-TOF MS has also been 
applied to determine antimicrobial susceptibility pat-
terns, and has produced reliable same-day results; this 
is a major advantage, as routine antimicrobial suscep-
tibility testing (AST) analyses typically need overnight 
incubation [6].
MALDI-TOF MS has also emerged as a diagnostic tool for 
bacterial typing, which could help to detect nosocomial 
outbreaks, with a putative beneficial impact on disease 
control and patient safety [7,8]. Hospital hygiene may 
also benefit from early identification of some emerg-
ing and clinically relevant pathogens [9]; in this con-
text, the rapid identification of pathogens, even at the 
subspecies or serotype level, may positively impact the 
time until patient isolation and the prompt initiation of 
the appropriate drug therapy. In some circumstances, 
such as the recent Mycobacterium chimaera outbreak, 
early identification of atypical mycobacteria would also 
prove useful to detect such case clusters [10].
Altogether, in this review we aim to demonstrate that 
MALDI-TOF MS represents a versatile diagnostic tech-
nology with great potential to improve the identifica-
tion of microorganisms and to impact public health 
2 www.eurosurveillance.org
by providing important information for optimised anti-
microbial stewardship and disease prevention and 
control.
Methods
A review of the available scientific literature was car-
ried out. We searched the United States (US) National 
Institutes of Health’s National Library of Medicine 
PubMed database for articles published in English 
between January 2009 and October 2018, using the 
terms ‘MALDI-TOF’, ‘blood culture’, ‘bloodstream infec-
tion’, ‘antibiotic susceptibility testing’, ‘resistance 
mechanism’, ‘typing’, ‘highly pathogenic microorgan-
isms’, ‘identification’ and ‘diagnosis’.
Reference lists from published articles were also 
screened to find more literature on the topic. In addi-
tion, reports from the European Centre for Disease 
Prevention and Control (ECDC) were consulted to identify 
outbreaks and public health issues where MALDI-TOF 
MS was applied to detect the causing pathogen 
(https://ecdc.europa.eu/en/threats-and-outbreaks).
The articles identified in the search were screened 
based on the information included in their titles and 
abstracts. Studies with a scope other than the appli-
cation of MALDI-TOF MS on public health and hos-
pital hygiene issues, as well as duplicate studies, 
were excluded. Case reports, studies acknowledging 
regional or very local microbiological problems (indi-
cated by a very limited number of samples (n <10) and 
reviews were also excluded, though their reference lists 
were checked for related literature. Subsequently, the 
remaining articles were each assigned to an author for 
review, according to their area of expertise (including 
direct application of MALDI-TOF MS on blood cultures 
(GG), detection of resistance mechanisms (AC, EC), 
identification of public health-relevant microorganisms 
and typing with MALDI-TOF MS (BRS, EC).
Results
Literature selection
A total of 9,709 articles were found using the selected 
keywords. Based on the information in the titles 
and abstracts, 6,322 studies were out of scope and 
were therefore excluded. Among the remaining 3,387 
papers, 1,707 appeared in the search results more than 
once and 790 reviews did not contribute new content 
because they reproduced results previously obtained 
by other authors in a different geographical area; these 
were also excluded. Articles written in languages other 
than English (n = 398) and 76 case reports referring 
to a very limited number of samples or patients were 
excluded as well (Figure 1).
At this stage, the remaining number of references was 
416. During a second review, studies acknowledg-
ing regional or very local microbiological problems 
(n = 122) and those where MALDI-TOF MS was used as 
an identification tool but its performance was not the 
objective of the study (n = 176) were also excluded. In 
addition, in order to fall within the maximum number of 
references for publication, only the most recent articles 
showing similar design and results were included; all 
relevant articles are covered here (Figure 1).
Finally, 108 original articles demonstrating proof of 
concept, as well as a clear impact on microbiology and 
the microbiology laboratory praxis regarding the appli-
cation of MALDI-TOF MS, were included in this review.
Implementation and clinical impact of 
performing MALDI-TOF MS on blood culture 
pellets
One of the most impactful uses of MALDI-TOF MS is 
its ability to identify microorganisms grown in blood 
cultures [11]. This application has shown to provide 
reliable identification of possible contaminants and 
disease-causing pathogens, as well as to reduce 
Figure 1
Flowchart of the literature retrieved and retained in 
review of MALDI-TOF MS use in public health and 
hospital hygiene, 2018
Articles screened using the terms ‘MALDI-TOF MS’ and
 ‘blood culture’, ‘bloodstream infection’, ‘antimicrobial 
susceptibility testing’, ‘resistance mechanism’, ‘typing’, 
‘identification’ or ‘diagnosis’ (N = 9,709)
Title, abstract scope (n = 6,322)
Articles in study scope after screening of 
abstract and titles (n = 416)
Duplicate studies (n = 1,707)
Reviews (n = 790)
Language other than English
 (n = 398)
Case Reports (n = 76)
Local impact onlya (n = 122)
Not within study scopeb (n = 176)
Similar studies  (n = 11)
Studies with useful information regarding MALDI-TOF and 
public health included in the review (n = 108)
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a Regional or very local microbiological problems indicated by a 
limited number of samples (n <10).
b MALDI-TOF MS was used as an identification tool, but its 
performance was not the objective of the study.
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turnaround time (TAT) to final identification, since 
overnight culture on agar media is not necessary [4,12].
Already in 2010, several authors proposed to prepare 
a bacterial pellet from positive blood cultures in order 
to fasten pathogen identification [13-15]. Since then, 
a variety of protocols have been used that reported 
identification of the aetiological agent of bacteraemia 
in 70–80% of cases, with accuracy greater than 99% 
(reviewed in [16]).
In these protocols, sample preparation aims at concen-
trating the microorganisms present in the blood culture 
by using differential centrifugation and washing steps. 
Then, the pellet can be spotted directly on the MALDI 
target for identification [17] or be submitted to a protein 
extraction procedure [18]. The use of the SepsiTyper 
kit (Bruker Daltonics, Billerica, Massachusetts, US) 
has also been reported for this purpose [19]; its per-
formance was shown to be similar to the direct and 
protein-extraction methods, but it provided superior 
results for yeasts identification. These results were 
supported by several studies [3,20]. In-house methods 
using different reagents also reported improved iden-
tification of yeasts and fungi in blood cultures [21,22]. 
Croxatto et al. developed an ammonium chloride-
based approach to lyse red blood cells and obtain a 
clean bacterial pellet [23]. A short incubation step right 
after the blood culture bottle is flagged positive was 
also tested successfully [24]. The detection of beta-
lactamases and carbapenemases using MALDI-TOF MS 
can also be applied on the obtained pellet. The proce-
dure is detailed further down in this review [6,25].
So far, the drawback of MALDI-TOF MS directly on 
blood culture detected so far is the inability to iden-
tify all bacteria in a polymicrobial infection [17]. It has 
been overcome by the development of several AST 
approaches coupled to the identification of the caus-
ing pathogen (Figure 2).
The advantage of MALDI-TOF MS over conventional 
methods is that it offers a reliable identification of the 
pathogen and AST results can be obtained within one 
working shift in a rapid and inexpensive manner [26]. 
The clinical impact of the implementation of MALDI-TOF 
MS on blood cultures has been measured; in a study by 
Clerc et al. [5], MALDI-TOF MS allowed the adjustment 
of antibiotic treatment in 35.1% of the bacteraemia 
cases analysed. Without considering the centrifugation 
steps, the cost was calculated to be ca EUR 1.43 per 
sample tested, whereas the hospital stay was shown 
to be reduced by ca 2 days, depending on the patient 
type and the appropriateness of patient management 
[26,27]. Due to common use of carbapenems for sep-
tic shock at their study site, Clerc et al. observed anti-
biotic streamlining more often than broadening, with 
routine MALDI-TOF MS applied to blood culture pellets 
having a clear positive impact on reducing the usage of 
carbapenems and other broad-spectrum antibiotics [5].
A recent prospective study confirmed that identifica-
tion of the aetiological agent of bacteraemia by MALDI-
TOF MS led to a shorter time to adequate antibiotic 
treatment [28]. In this study, patients with  ampC-pos-
itive, Gram-negative bacteriaemia rapidly identified by 
MALDI-TOF MS were optimally treated within 48 hours.
Thus, in several centres the implementation of MALDI-
TOF MS for the routine identification of microorgan-
isms directly from blood culture pellets has shown that 
it may significantly impact the streamlining of antibi-
otics, with a likely positive impact on the antibiotic 
resistance rate.
Identification and typing of epidemiologically 
relevant pathogens
The high specificity shown by MALDI-TOF MS in dif-
ferent studies encouraged researchers to further ana-
lyse the protein spectra obtained for identification of 
different microorganisms and to attempt comparison 
between subpopulations.
Food-borne pathogens
Discrimination at the subspecies or even serotype 
level has been researched for different bacterial gen-
era of public health interest. For  Salmonella  spp., the 
finding of specific peaks that allow genus-, species-, 
subspecies- and even serotype-level discrimination 
has been described by Dieckmann et al. [29]. Using a 
decision tree based on the presence/absence of spe-
cific peaks, corresponding mainly to ribosomal pro-
teins, the authors achieved correct identification of the 
most commonly encountered  S. enterica  subsp.  enter-
ica  serotypes with 100% sensitivity and specificity. 
More recently, a study using similar peaks as serotype 
biomarkers and ad hoc software allowed 94% of 
correct S. enterica subsp. enterica serotype assignment 
using a set of 12 species-specific peaks [30]. The 
authors reported up to 96% correct serotype identifi-
cation when the software reduced the number of bio-
markers used to 10, with no impact on the specificity 
of the analysis. It is noteworthy that both studies used 
a whole-cell approach for serotyping, which requires a 
limited number of reagents and short TAT. The manual 
process of peak analysis can be more time-consuming 
and requires trained personnel. However, this require-
ment can be avoided by implementing specific soft-
ware for peak analysis. The use of free software such 
as MALDIQuant [31] allows the simultaneous analysis 
of many spectra, with the necessity of a trained bioin-
formatician as the only drawback.
Further important food-borne pathogens that have been 
successfully subtyped with MALDI-TOF MS are Shiga-
toxin producing Enterobacteriaceae [9]. The analysis of 
peak profiles yielded two important biomarkers that 
allowed correct identification of 103 of 104 Escherichia 
coli O104:H4 isolates from an outbreak that took place 
in northern Germany [9]. The implementation of MALDI-
TOF MS from isolates spotted directly on a MALDI tar-
get plate or after a formic acid/acetonitrile extraction 
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renders this methodology very rapid, since the protein 
spectra can be obtained within minutes.
This approach has also allowed the discrimination 
of Listeria monocytogenes, a pathogen associated with 
a high mortality rate (20–30%) [32]. Beyond correct 
species-level identification of  L. monocytogenes  after 
culture conditions standardisation, the analysis of the 
protein spectra has allowed the source tracking of  L. 
monocytogenes  isolates from dairy sources [33] and 
the correct serotype assignment from clinical samples 
[34]. In addition,  L. monocytogenes  subtypes can be 
discriminated using the automated MALDI Biotyper 
(MBT) subtyping module developed by Bruker Daltonics 
[35].
Clostridium difficile
The implementation of MALDI-TOF MS for typing 
of  Clostridium difficile  has yielded successful results 
[36]. High molecular weight proteins from 500 isolates 
were analysed and high correlation with PCR ribotypes 
(89.0%) was reported. The availability of this easy-
to-perform typing method allows rapid and accurate 
screening of outbreak-related  C. difficile  clones and 
helps epidemiologists and public health professionals 
to follow and control putative outbreaks.
Respiratory pathogens
Several respiratory pathogens of public health impor-
tance have been shown to be reliably identified using 
MALDI-TOF MS.  Legionella  spp. was identified from 
environmental samples in two different hospitals in a 
rapid and reliable manner [37,38].
Attempts to discriminate  Streptococcus pneumo-
niae  from the members of the  S. mitis  complex have 
yielded a panel of specific marker peaks that allow 
species assignment to  S. pneumoniae  isolates and 
the most common non-pneumococcal species (S. 
mitis and S. oralis) [39,40]. Compared with the culture 
from suspected isolates in the presence of an optochin 
disk, this MALDI-TOF MS application allows a reduction 
in TAT and laboratory costs [39].
Another group of important respiratory pathogens are 
the members of the  Mycobacterium  genus. MALDI-
TOF MS cannot differentiate among the species 
comprising the  Mycobacterium tuberculosis  complex. 
Nevertheless, its implementation for the identification 
of non-tuberculous mycobacteria (NTM) has been 
useful for evaluating the clinical significance of 
the microorganism recovered by culture of various 
clinical samples. Around 60 NTM species have been 
shown to act as opportunistic human pathogens 
causing pulmonary disease with symptoms similar 
to tuberculosis lymphadenitis in children associated 
with  M. avium  and  M. scrofulaceum, as well as skin 
diseases and disseminated infections in immunocom-
promised patients [41,42]. In this scenario, MALDI-TOF 
MS has shown to provide reliable species-level identifi-
cation in almost 100% of the cases [43] and the sample 
processing methods available are easy to apply, require 
little hands-on time and are widely standardised [44].
However, MALDI-TOF MS applied to NTM grown on liq-
uid medium exhibited a low sensitivity [45]. This draw-
back has been overcome, however, by some authors 
using an improved bead-based method for cell disrup-
tion. The implementation of this method reduced the 
TAT up to 2–3 weeks [46]. Closely related NTM species 
are often identified by MALDI-TOF MS at a complex 
level. However, Fangous et al. developed an algorithm 
that allowed the accurate discrimination between 
three subspecies within the  Mycobacterium absces-
sus  complex, namely  M. abscessus subsp.  absces-
sus,  M. abscessus  subsp.  massiliense  and  M. 
abscessus subsp. bolletii [47]. The algorithm was based 
on the presence/absence of five specific peaks that cor-
related with the three subspecies. The discrimination 
of the subspecies within the M. abscessus complex was 
demonstrated as well by Kehrman et al. using principal 
component analysis [48]. In both cases, the discrimi-
nation of the subspecies was accurate and allowed for 
improved patient management due to the different 
antibiotic susceptibility pattern of each member of 
the  M. abscessus  complex. More recently, Pranada et 
al. have achieved a highly robust and accurate discrim-
ination between  M. intracellulare  and  M. chimaera  by 
peak analysis [10]. Their approach supports the use of 
MALDI-TOF MS for the accurate discrimination of NTM 
isolates associated with heater/cooler devices used for 
extracorporeal cardiopulmonary support, an important 
issue in hospital hygiene and infection prevention [49].
Biosafety level Risk Group 3 pathogens
Highly pathogenic microorganisms are a major concern 
for their potential to be used as bioterrorism agents. 
The identification of Risk Group 3 bacterial patho-
gens with MALDI-TOF MS was assessed by different 
groups [50-52]. The authors reportedly showed no 
identification of these microorganisms when propri-
etary databases were employed. However, the use of 
the Security Relevant reference library, developed by 
Bruker Daltonics, allowed between 52.5–77.0% correct 
species assignment, although misidentifications with 
neighbour species were also reported [52]. The rate of 
correct species assignment reached the totality of the 
isolates tested only (i) when expanded with in-house 
libraries and/or (ii) when improved software for spec-
tra analysis were used [51].
Recently, the US Centers for Disease Control and 
Prevention (CDC) collaborated with Bruker Daltonics in 
the construction of an expanded library for Risk Group 
3 pathogens. This database can be accessed online 
(https://microbenet.cdc.gov/).
Finally, MALDI-TOF MS was able to identify the emerg-
ing pathogen  Candida auris. The Biotyper updated 
Research Use Only (RUO) database already contains 
nine reference spectra from this pathogen, which 
allowed the discrimination from  C. haemuloni  without 
using an expanded library (data not shown).
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Antimicrobial susceptibility detection using 
MALDI-TOF
Even without performing AST, the identification of micro-
organisms by MALDI-TOF MS impacts antimicrobial 
stewardship since the common susceptibility pattern of 
the identified microorganism can be largely deduced. 
This information can already be partially obtained by 
direct examination of the sample after performing a 
Gram staining, but MALDI-TOF MS goes one step fur-
ther by giving at least the genera of the microorganism. 
Concerning Gram-negative rods, identification of group 
3 Enterobacterales or a Stenotrophomonas spp. isolate, 
for example, will modify the antibacterial stewardship. 
It is the same for Gram-positive cocci and the possibil-
ity to distinguish Enterococcus faecium from E. faecalis, 
for example.
Considering the continuous emergence of acquired 
antibiotic/antifungal drug resistance, the need for 
same-day, full AST results become urgent. From this 
perspective, several studies have investigated the 
use of MALDI-TOF MS to perform AST. MALDI-TOF AST 
assays were first developed to detect specific peaks 
of resistant strains by peak picking approaches [53-
55]. Most of these studies, however, concern detec-
tion of drug hydrolysis/modification (reviewed in [56]). 
Recently, some MALDI-TOF MS assays aimed at detect-
ing drug resistance independently of the biological 
mechanism, evaluating the growth of a microorganism 
in the presence of a given drug [57-59].
The peak picking approaches
The first MALDI-TOF AST study was performed 
on Staphylococcus aureus to detect meticillin resistance 
[60]. Comparing the lists of peaks, some peaks specific 
for meticillin-resistant S. aureus (MRSA) and meticillin-
susceptible  S. aureus  (MSSA) strains were identified. 
Further studies were then performed on larger sets of 
strains and on averaged spectra obtained from several 
replicates for a given strain. Cluster analysis was per-
formed on the obtained peak list to discriminate MRSA 
from MSSA strains [61]. Interestingly, some authors of 
the first study also demonstrated that the cluster anal-
ysis result is modified depending on the growth media 
[62]. In contrast, Bernardo et al. showed that peak pro-
files were very stable regardless of the growth medium 
used. However, this study failed to define a clear peak 
signature for MRSA [63].
Other groups performing peak picking could discriminate 
between teicoplanin-susceptible vs -resistant staphylo-
cocci by analysing peak lists of laboratory-engineered 
mutant strains [64]. More recently, vancomycin inter-
mediate-resistant  Staphylococcus aureus  (VISA) and 
vancomycin-susceptible Staphylococcus aureus (VSSA) 
could be discriminated by the identification of 22 
relevant peaks using linear regression analysis, 
followed by a principal component analysis (PCA) on 
the identified peaks [65]. Once again, the influence 
of the growth medium on the obtained spectra was 
documented [65]. In 2018, Asakura et al. [66] further 
developed the machine learning approach initiated by 
Mather et al. to discriminate profiles of VISA among 
MRSA and heterogeneous VISA (hVISA) among MSSA, 
with 99% sensitivity for both. They also developed an 
‘all-in-one’ online software publicly available to ana-
lyse in-house spectra [66]. The same approach was 
used earlier to discriminate cfiA-positive and cfiA-neg-
ative Bacteroides fragilis [67].
Since antimicrobial resistance is often due to the pro-
duction of enzymes modifying the microorganism 
metabolism or degrading the drug, some MALDI-TOF 
MS studies developed assays to identify peaks cor-
responding to such enzymes. Studies were then per-
formed to detect disappearance of peaks corresponding 
to  E. coli  or  Klebsiella pneumoniae  porins in spectra 
of strains with high resistance against beta-lactams 
[53]. This approach allows discrimination between car-
bapenemase expression and loss of porin expression 
conjugated with AmpC or extended Spectrum Beta-
Lactamase (ESBL). Other groups were able to identify 
the peak of beta-lactamase at 29,000 m/z in ampicil-
lin-resistant E. coli [55]. Concerning the detection of B. 
fragilis resistant to carbapenems, peaks specific to the 
IS insertion upstream of the cfiA gene were determined 
and a MBT subtyping module from Bruker Daltonics’ 
was released to detect them [35].
Meticillin resistance in  Staphylococcus  is due to the 
acquisition of the mecA or mecC gene. The mecA gene is 
often acquired in parallel to the psm-mec gene coding 
for a toxin. Rhoads et al. specifically detected a peak 
near 2,415 m/z (± 2.00 m/z) that correlated with meticil-
lin resistance (mecA carriage) in a series of consecutive 
staphylococcal blood culture isolates; this peak was 
present in 37% of the MRSA and 0% of MSSA strains 
[68]. Recently, Bruker Daltonic’s MBT subtyping mod-
ule included the detection of a peak corresponding to 
the PSM-mec peptide in Staphylococcus aureus spectra 
[35].
Detection of drug hydrolysis
The most important outcome of using MALDI-TOF AST 
so far was the detection of antimicrobial modifica-
tions, either quinolones acetylation or beta-lactam ring 
hydrolysis, leading to mass shift of 43 Da and 18 Da, 
respectively [56,69,70]. Beta-lactam ring hydrolysis is 
directly followed by a decarboxylation corresponding 
to a minus 44 Da shift. Thus, beta-lactamase hydroly-
sis rather appears as a minus 26 Da shift [71].
In 2011, Sparbier et al. established an interesting table 
of detected peaks for each type of beta-lactams before 
and after hydrolysis decarboxylation, in presence or 
absence of salts [70]. They then correlated the calcu-
lated data with measured data on strains incubated for 
3 hours with the different drugs. By visual peak analys-
ing, they obtained the same susceptibility and resist-
ance results as routine AST methods. Further studies 
aimed to detect ESBL  Enterobacterales  through third-
generation cephalosporins degradation [70,72]. To 
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quantify the hydrolysis, Jung et al. calculated the loga-
rithm of the hydrolysed/non-hydrolysed peaks. This 
so-called LogRQ ratio discriminates drug susceptibility 
with 100% sensitivity and 91.5% specificity [72], even 
if criteria to interpret the ratio were not clearly defined. 
In a subsequent study, De Carolis et al. calculated the 
average intensity of the hydrolysed vs non-hydrolysed 
peaks, and compared them with the positive and nega-
tive control peaks [73]. Both studies investigated the 
possibility to detect enzyme activity directly in the 
blood culture pellet and obtained sensitivity and speci-
ficity of ca 87% and 98%, respectively.
The majority of the MALDI-TOF AST studies, however, 
focused on carbapenemases detection, as they rep-
resent a challenge for hospital hygiene as an emer-
gent antimicrobial resistance mechanism. Several 
studies successfully detected carbapenemase-pro-
ducing bacteria using different carbapenems as sub-
strate, such as ertapenem [74,75], imipenem [76,77] 
and meropenem [78,79]. However, OXA48 carbap-
enemase in  Enterobacteriaceae  or imipenemases 
in  Pseudomonas aeruginosa  remain difficult to 
detect [80,81]. The addition of a bicarbonate buffer 
improved hydrolysis by  Enterobacteriaceae  of ertap-
enem and meropenem, but not imipenem [77,82]. 
Similarly, addition of zinc ion (Zn2+) conserves activ-
ity of zinc-dependent  P. aeruginosa  imipenemases 
[83]. However, Rotova et al. highlighted a slightly 
better efficacy of meropenem supplemented with 
sodium dodecyl sulfate (SDS) and bicarbonate to 
detect  Enterobacteriaceae  and  Pseudomonas  carbap-
enemases than imipenem plus Zn2+ [84].
All these MALDI-TOF MS detections of drug modifi-
cations have lead, so far, to the development of the 
MBT STAR-BL software (Bruker Daltonics) and to one 
carbapenemase detection kit called MBT STAR-Carba 
Kit (Bruker Daltonics). Recent studies demonstrated 
the efficacy of this software with a concomitant iden-
tification and detection of ESBL or carbapenemase in 
around 1.5–5.2 hours, instead of 12–48 hours, with 
conventional routine protocols [85,86].
Detection of global spectra modifications in the 
presence of a drug
One promising use of MALDI-TOF AST consists of 
comparing spectra obtained from microorganisms in 
absence or presence of an antimicrobial agent. This 
approach was first developed in 2009 to discrimi-
nate between fluconazole-susceptible and -resist-
ant C. albicans strains [87]. Authors compared spectra 
of Candida cells incubated in increasing concentrations 
of fluconazole. The minimal profile change 
concentration (MPCC) was determined as the lower 
concentration of drug needed to observe modification 
in the  C. albicans  spectra. Like for classical minimum 
inhibitory concentration (MIC), breakpoints were 
defined and then susceptible or resistant phenotypes 
could be easily determined after a few hours of incuba-
tion in fluconazole [87], allowing same-day antifungal 
susceptibility testing results. De Carolis et al. and Vella 
et al. further developed spectra comparison, perform-
ing a cross correlation index (CCI) matrix with spectra 
obtained in only three conditions: no drug, breakpoint 
and high concentration with a reduced 3-hour incuba-
tion [88,89]. They also adapted the method to echino-
candins [90], other triazoles and other Candida species 
[91]. The overall agreement of the MALDI-TOF AST with 
the Clinical and Laboratory Standards Institute (CLSI) 
method ranged from 54–97%, depending on the spe-
cies and the drug [92].
Comparison of spectra in the presence of a drug was 
also developed to determine bacterial resistance. 
It consists of a semiquantitative evaluation of the 
growth measuring intensity of different peaks in pres-
ence/absence of a drug following an internal standard 
[93]. First assays were performed using meropenem 
and Klebsiella  strains [57]. Best results were obtained 
after 1 hour of incubation, reaching 97.3% sensitivity and 
93.5% specificity. Like for the yeast assays described 
earlier, breakpoints were determined to distinguish 
susceptible from resistant strains. This approach was 
enlarged to cefotaxime, piperacillin-tazobactam, cipro-
floxacin and gentamicin, other Enterobacteriaceae and 
non-fermenting Gram-negative rods, and it was 
adapted to blood culture samples [58]. The same meth-
odology was tested for mycobacteria AST and allowed 
shortening of the TAT to one week for the NTM [59]. An 
example of such methodology is the MBT-ASTRA kit 
(MALDI BioTyper Antibiotic Susceptibility Test Rapid 
Assay, Bruker Daltonics), a promising tool for low-cost, 
same-day AST results on a wide range of pathogens 
and drugs [94-97].
Other applications of MALDI-TOF in public 
health
The rapid acquisition of protein spectra using MALDI-
TOF MS has been implemented as a diagnostic tool 
for the identification of infection markers. For this 
purpose, the spectra are usually obtained directly 
from clinical samples, mainly serum or whole blood 
[98-100]. This approach could be useful in instances 
where the pathogen is seldom detected, as is often 
the case for suspected but unconfirmed fungal infec-
tions and for slow-growing microorganisms such as 
some  Mycobacterium  species. Precisely for these two 
applications, several authors have recently published 
interesting data [99-102].
Biomarkers for diagnosing fungal pathogens
In the case of fungal infections, Sendid et al. published 
the first evidence of the presence in serum samples of 
a disaccharide directly related to experimental invasive 
candidiasis in a mouse model and also in human sera. 
They further simplified this methodology and imple-
mented it as routine identification of this biomarker 
from serum of patients with invasive candidiasis, 
invasive aspergillosis and mucormycoses [100]. Their 
results showed that the detection of the disaccharide 
marker (365 m/z) performed similarly to beta-D-glucan 
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and galactomannan, thus complementing those tests. 
Although the detection of this biomarker has not been 
validated yet, its implementation could represent a 
rapid, inexpensive and easy-to-perform means for 
detecting invasive infections caused by a wide range 
of fungal species.
The detection of acute phase proteins with MALDI-
TOF MS has also been tested as a marker of antifun-
gal treatment response in a rabbit model of invasive 
pulmonary aspergillosis [103]. Although these proteins 
are not specific to fungal infection, their presence in 
infected rabbits was confirmed, as well as important 
changes in their expression as a response to antifungal 
treatment.
Biomarkers for diagnosing active and 
latent Mycobacterium tuberculosis infection
Few studies reported the identification of specific 
plasma biomarkers for latent tuberculosis infec-
tion (LTBI), using MALDI-TOF that could differenti-
ate between healthy individuals and those with LTBI. 
In their study, Zhang et al. (2014) used weak cat-
ion exchange magnetic beads (MB-WCX Kit, Bruker 
Daltonics) to recover plasma proteins even in low 
concentration. They then acquired spectra of plasma 
proteins and analysed them with specific algorithms. 
This combination allowed them to develop a model 
to discriminate between healthy and LTBI individu-
als, based on the presence/absence of specific peaks 
[102]. The same concept was also developed by 
Sandhu et al., who detected three regions along the 
protein spectra (around 5.8kDa, 11.5kDa and 21kDa) 
of plasma samples that also allowed discrimination of 
healthy individuals from patients with active TB infec-
tion and symptomatic LTBI patients with 87–90% accu-
racy [101]. The advantage of these approaches is that 
the methodology can be easily standardised, thanks to 
the use of the commercial kit for protein recovery from 
plasma. However, the protein ranges analysed by both 
studies are different and so are the results obtained in 
both cases. The identification of accurate biomarkers 
for TB infection would make MALDI-TOF MS a valuable 
screening tool, though the marker peaks need further 
confirmation by molecular or serological methods.
Biomarkers for diagnosing viral infections
Finally, a similar approach has been applied recently 
for the identification of a panel of 10 respiratory 
viruses from infected cell cultures [104]. The authors 
utilised four commonly used cell lines to establish 
a background of protein peaks derived from the cell 
Figure 2
Workflow for the identification of microorganisms from positive blood, review of MALDI-TOF MS use in public health and 
hospital hygiene, 2018
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culture and then found specific viral peaks using refer-
ence viral strains. The marker peaks were also robustly 
found in cell cultures infected with viruses from clini-
cal samples. The authors found this methodology to be 
poorly discriminatory for closely related viruses. The 
same authors also reported the discrimination of three 
poliovirus serotypes using MALDI-TOF MS [105].
Discussion and conclusions
The implementation of MALDI-TOF MS has changed the 
way many microorganisms of clinical and public health 
interest are identified. Anaerobic bacterial species, 
yeasts, mycobacteria and an increasing number of 
moulds can be reliably identified using this technology. 
This fact is reflected in the amount of literature about 
this subject published during the past 10 years (Figure 
2). Although only articles referenced in PubMed have 
been reviewed here, the large number of publications 
in this database reporting the use of MALDI-TOF MS to 
rapidly identify a wide range of microorganisms with 
public health relevance worldwide provides an up-to-
date overview of the role of MALDI-TOF MS in this field.
Despite the successful results reported using MALDI-
TOF MS and the wide range of scenarios where these 
findings could be applied, further studies are neces-
sary to standardise the applied procedures and to con-
firm the reproducibility of the results. In a recent study, 
the methodology applied for typing was evaluated in 
different laboratories [106]. Technical and biological 
replicates were analysed in order to assay the repro-
ducibility of the marker peaks detected in different 
populations of microorganisms. Their results displayed 
a reproducibility of technical and biological repli-
cates ranging between 96.8–99.4% and 47.6–94.4%, 
respectively. Thus, the authors proposed the evaluated 
technology as a first-line screening tool in outbreak 
analysis and epidemiological studies. In addition, the 
use of classifier algorithms and linear support vector 
machine (SVM) allowed the correct classification of 
the isolates used for validation. The implementation of 
these bioinformatics tools, together with standardised 
procedures and the available software, will turn MALDI-
TOF MS into a reliable reference methodology for typ-
ing isolates. Free software such as MALDIQuant [31] or 
proprietary software like FlexAnalysis and ClinProTools 
(Bruker Daltonics) or Bionumerics (Applied Maths, 
Sint-Martens-Latem, Belgium) allow automatic analysis 
of large amounts of protein spectra and facilitates the 
application of different classifiers for the correct iden-
tification of bacterial populations.
Additionally, available databases constructed by 
MALDI-TOF MS users can now be accessed online for 
the accurate identification of certain groups of micro-
organisms (https://microbenet.cdc.gov/) [37,107,108].
Taking into account the great impact of MALDI-TOF MS 
during the past 10 years, the knowledge that has been 
acquired during this time and the great flexibility of the 
technique, we think that its influence in public health 
will only become bigger in the coming years. Its use for 
resistance mechanism detection, typing and peak bio-
marker identification makes MALDI-TOF MS an excellent 
tool for monitoring the epidemiology of highly resistant 
or virulent pathogens, for outbreak detection and for 
screening of isolates within an outbreak, as the rapid 
acquisition and analysis of the protein spectra would 
facilitate prompt implementation of isolation measures 
and the identification of the affected patients. DNA 
sequencing tests could, therefore, be used as a con-
firmatory test only, to save time and resources.
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